EBOS confident of future
April 1, 2016
EBOS ceo Patrick Davies says he
is confident of delivering another
year of double-digit profit growth
for shareholders in 2016, with
the company’s half yearly report
released this week indicating
“sound performances” across both
its healthcare and animal care
operations.
Davies said the half year result
(PD 24 Feb) saw solid wholesale
revenue growth in the Australian
pharmacy market for EBOS, assisted
by “increased levels of activity,
particularly in the non-prescription
channel”.
He said the first half group
results with revenue of $3.4b, up
8.3%, also reflected the benefits
of acquisitions and investments
undertaken in previous periods,
which have now cycled through a
full 12 months of ownership.
Pharmacy wholesaling comprised
44% of the company’s total
operational revenue, while the
group’s retail pharmacy amounted
to 6% of the total.
Earnings before income tax,
depreciation and amortisation for
the healthcare business increased
12.7% with strong growth in
both Australian and New Zealand
operations.
Australian operations reflected
convincing performances across
pharmacy, institutional healthcare
and contract logistics Davies said.
Non-prescription business
activity dominated the growth of
wholesaling revenue, he added,
with the company’s Onelink
Australia business profiling the
firm’s operational capacity as
well as the expertise of staff and
supporting infrastructure.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Apr 16To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Apr 16
